-
CellBion eyes global expansion in radiopharmaceuticals after Kosdaq IPO
26 Sep 2024 06:41 GMT
CellBion, a Korean developer of radioisotope-based cancer therapeutics, announced its plans for global growth following its recent Kosdaq listing. At a press conference on Wednesday, CEO Kim Kweon outlined the company's vision to develop new …
-
MICKEY MAURER: Endocyte believers finally have their day
26 Oct 2018 20:44 GMT
My February 2018 column touted Endocyte, then trading around $3 … of a fledgling company called Endocyte based in West Lafayette. … a sale, merger or an IPO. Our new regulations also … millions from successful Hoosier companies. Endocyte will not be required to …
-
Endocyte's $2.1B deal with Novartis comes after years of setbacks
18 Oct 2018 16:34 GMT
… the time of the IPO, Endocyte was in the second … , behind the scenes, Endocyte was negotiating with German chemical … molecule drug conjugate, which Endocyte had been researching and … After months of negotiation, Endocyte make another momentous announcement in …
-
Rounds Report: Endocyte Rallied While The Tricida IPO Was A Success
06 Jul 2018 18:50 GMT
… experience significant nausea/vomiting.
Endocyte’s technology is ingenious, which … . Figure 2: Therapeutic pipeline. (Source: Endocyte) Moving toward the assessment of … , 2018, the company executed an initial public offering (“IPO”) of 13,455,000 common …
-
The Week Ahead In Biotech: PDUFA Dates, Earnings, IPOs And More
07 May 2018 00:46 GMT
… (NASDAQ: XENE)
Wednesday, May 9
Endocyte, Inc. (NASDAQ: ECYT)
FibroGen Inc … )
Fibrocell Science Inc (NASDAQ: FCSC)
IPO
Immuno-oncology company Abpro is …
-
Endocyte, Now Included In IBB, Has A Strong Clinical-Stage Asset
31 Jan 2018 20:18 GMT
… I decided to examine Endocyte first. Why Endocyte turned up positive in … capitalization, $ millions notes ECYT Endocyte, Inc. 153 cancer & … do with who did the IPO than with the probable … Seattle Genetics (SGEN).
Source: endocyte.com
Endocyte's Phase 3 …
-
Endocyte (ECYT) Reports Wider
14 Mar 2017 22:55 GMT
… million during the quarter.
Endocyte’s share price has increased … compensation expense.
Pipeline Update
Endocyte is focused on the development … head start on potential tech IPOs that are popping up … -dropping growth. Download this IPO Watch List today for free …
-
Sutro Biopharma: Revenue-Generating Platform Positioned For Growth
21 Apr 2020 22:10 GMT
… agent vinblastine originally developed by Endocyte (NASDAQ:ECYT). Despite promising Phase … , concurrently with Sutro's initial public offering approximately $10M of shares. Sutro …
-
CAR-T Cell Therapy Market Report, Q4 2019: Kymriah and Yescarta Have Created a Robust Landscape
28 Jan 2020 11:24 GMT
… CAR-T Deals
11.3 Initial Public Offering (IPO)
11.4 Key CAR-T … -T Immunotherapy Platform
18.18 Endocyte, Inc.
18.18.1 LU …
-
Global CAR-T Cell Therapy Market Market Size, Forecasts, Trials & Trends Report 2019: $20 Billion of Market Capitalization from the CAR-T Companies in 2018, Market has Continued to Gain Momentum
14 Feb 2019 14:20 GMT
… CAR-T Deals
11.3 Initial Public Offering (IPO)
11.4 Key CAR-T … .17 DiaCarta, Inc.
18.18 Endocyte, Inc.
18.19 F1 Oncology …
About
© 1995-2025